Aperiam harum

December 1, 2023

China’s Best Impact Investments of the Year Awards were solemnly announced, with BOCG winning the “2023 For Good Award | Top 10 Impact Investment Institution”. Dr. Yanling Wen, Chief Medical Officer of BOCG, was invited to participate in a roundtable forum to discuss the challenges and opportunities of ESG impact investment in China.

July 1, 2022

Four well-achieved experts with industry, academic and clinical background respectively, have joined its Scientific and Industrial Advisory Board ("The Advisory Board") to strengthen its investment and operational capabilities. They are Dr. Yan Shao, Dr. Yongqin Zeng, Prof. Jixi Li and Prof. Yanling Wen.

April 11, 2022

BOCG has become an official signatory to the United Nations-supported Principles for Responsible Investment ("UN PRI"). As one of the Chinese leading investment firms focusing on healthcare sector to join UN PRI, BOCG is committed to promoting responsible investment and empowering sustainable development of the portfolio companies.